* AxoGen Inc AXGN.OQ reported a quarterly adjusted loss of
1
cent per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 12
cents per share.
* Revenue rose 18.4% to $36.96 million from a year ago;
analysts
expected $36.19 million.
* AxoGen Inc's reported EPS for the quarter was a loss of 10
cents.
* The mean earnings estimate of analysts had fallen by
about 11.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* AxoGen Inc shares had fallen by 10.4% this quarter and
gained 14.0% so far this year.
* The company reported a quarterly loss of $4.32 million.
* Wall Street's median 12-month price target for AxoGen Inc
is
$20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 02:33 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.12 -0.01 Beat
Jun. 30 2022 -0.14 -0.06 Beat
Mar. 31 2022 -0.15 -0.20 Missed
Dec. 31 2021 -0.13 -0.08 Beat